Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VNRX Relative to the S&P 500

VNRX Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the VolitionRX Ltd. (AMEX:VNRX) seasonal charts above shows that a Buy Date of August 29 and a Sell Date of January 24 has resulted in a geometric average return of 25.14% above the benchmark rate of the S&P 500 Total Return Index over the past 18 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 18 years by an average of 37.4% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

To download VNRX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VNRX